MMMarija V. Medovic

Marija V. Medovic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marija V. Medovic has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Variations of Redox Balance in Different Stages of Childhood Immune Thrombocytopenic Purpura

    by Rasa H. Medovic, Ivan M. Srejovic, Marija V. Medovic, Isidora M. Milosavljevic, Marina R. Nikolic, Aleksandra Z. Stojanovic, Milos B. Kuzmanovic, Predrag M. Djurdjevic, Sergey B. Bolevich, Vladimir P. Fisenko, et al.

    Background Few previous studies indicated the role of oxidative stress in the pathogenesis of childhood idiopathic thrombocytopenic purpura (ITP), but there are little data regarding changes in redox balance in different forms of the disease, and changes after therapeutic procedures. We aimed to investigate the values of pro-oxidants and antioxidative capacity in various forms of ITP before and after the applying therapy. Materials and Methods The research included 102 children, classified into the following groups: (1) newly diagnosed ITP (ndITP), (2) persistent ITP, (3) chronic ITP (chITP), and (4) control groups: (A) healthy control and (B) previously experienced ITP—healthy children who had been suffering from ITP earlier. During the clinical assessment, a blood sample was taken from the patients, from which the value of pro-oxidants (index of lipid peroxidation measured as TBARS, nitrites [NO2 −], as measurement of nitric oxide [NO] production, superoxide anion radical [O2 −], and hydrogen peroxide [H2O2]) and the capacity of antioxidant protection (activity of superoxide dismutase and catalase, and quantity of reduced glutathione) were determined spectrophotometrically. Results Our results demonstrated that values of pro-oxidants, especially reflected through the TBARS and O2 −, were the highest in the ndITP and exacerbated chITP groups. Also, the activity of the endogenous antioxidative defense system was the lowest in these groups. Intravenous immunoglobulin therapy in the ndITP group exerted the most prominent effect on the redox balance. Conclusion It can be concluded that severity and exacerbation of the ITP are closely related to the redox status. Parents and patients were informed about the research, and written consent was obtained from the parents, and from the patients themselves if they were older than 12 years, to participate in the research. Ethical approval was obtained from University Clinical Center Kragujevac, Kragujevac, Serbia (approval number 01-22-656). Conception and design of the study: R.H.M., Z.R.I., I.M.S., V.L.J.; acquisition of data: R.H.M., M.B.K., P.M.D., Z.R.I.; analysis and interpretation of data: R.H.M., I.M.S., M.V.M, I.M.M., M.R.N., A.Z.S., S.B.B., V.P.F.; drafting the article: R.H.M., I.M.S., V.L.J., A.Z.S. All authors approved the final version of the manuscript before submission. Received: 18 January 2023 Accepted: 02 June 2023 Article published online: 21 August 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Top Cited Papers
    Open Access

    Psoriasis between Autoimmunity and Oxidative Stress: Changes Induced by Different Therapeutic Approaches

    by Marija V. Medovic, Vladimir Lj. Jakovljevic, Vladimir I. Zivkovic, Nevena S. Jeremic, Jovana N. Jeremic, Sergey B. Bolevich, Ana B. Ravic Nikolic, Vesna M. Milicic, Ivan M. Srejovic

    Psoriasis is defined as chronic, immune‐mediated disease. Regardless of the development of new therapeutic approaches, the precise etiology of psoriasis remains unknown and speculative. The aim of this review was to systematize the results of previous research on the role of oxidative stress and aberrant immune response in the pathogenesis of psoriasis, as well as the impact of certain therapeutic modalities on the oxidative status in patients with psoriasis. Complex immune pathways of both the innate and adaptive immune systems appear to be major pathomechanisms in the development of psoriasis. Oxidative stress represents another important contributor to the pathophysiology of disease, and the redox imbalance in psoriasis has been reported in skin cells and, systemically, in plasma and blood cells, and more recently, also in saliva. Current immune model of psoriasis begins with activation of immune system in susceptible person by some environmental factor and loss of immune tolerance to psoriasis autoantigens. Increased production of IL‐17 appears to be the most prominent role in psoriasis pathogenesis, while IL‐23 is recognized as master regulator in psoriasis having a specific role in cross bridging the production of IL‐17 by innate and acquired immunity. Other proinflammatory cytokines, including IFN‐γ, TNF‐α, IL‐1β, IL‐6, IL‐22, IL‐26, IL‐29, or IL‐36, have also been reported to play important roles in the development of psoriasis. Oxidative stress can promote inflammation through several signaling pathways. The most noticeable and most powerful antioxidative effects exert various biologics compared to more convenient therapeutic modalities, such as methotrexate or phototherapy. The complex interaction of redox, immune, and inflammatory signaling pathways should be focused on further researches tackling the pathophysiology of psoriasis, while antioxidative supplementation could be the solution in some refractory cases of the disease.